Estrogenic hormones receptors in Alzheimer's disease

Area of Science:

• Endocrinology
• Neuroscience
• Gerontology

Background:

• Estrogens are vital hormones for female reproductive health, bone density, metabolism, and cognitive function.
• Menopause leads to decreased estrogen levels, impacting signaling through estrogen receptors (ERα, ERβ) and GPER.
• Reduced estrogenic signaling in the brain is linked to Alzheimer's disease (AD) progression in postmenopausal women.

Purpose of the Study:

• To review the involvement of estrogen receptors in the development and progression of Alzheimer's disease in aging women.
• To elucidate the mechanisms by which estrogen receptor signaling impacts brain health during menopause and aging.

Main Methods:

• Literature review of studies investigating estrogen receptors and Alzheimer's disease.
• Analysis of molecular pathways affected by estrogen decline in the aging female brain.
• Synthesis of current research on estrogen receptor subtypes (ERα, ERβ, GPER) in AD pathogenesis.

Main Results:

• Estrogen deficiency during menopause alters estrogen receptor signaling pathways crucial for neuronal function.
• Evidence suggests a protective role of estrogen signaling against AD pathology.
• Dysregulation of ERα, ERβ, and GPER pathways may contribute to cognitive decline and AD development in aging women.

Conclusions:

• Estrogen receptors play a significant role in modulating the risk and progression of Alzheimer's disease in women.
• Understanding estrogen receptor function is critical for developing targeted therapies for AD in postmenopausal women.
• Further research into estrogenic pathways may offer new avenues for AD prevention and treatment strategies.